Heads Of Medicines Agency Group Adds Another Authority Voice To Intense EU MDR Debate
Executive Summary
EU member state authorities overseeing devices have been putting out a series of messages that promise action to ease the implementation chaos surrounding the EU’s new medtech regulations.
You may also be interested in...
European Parliament Calls For Risk-Related Extensions Under MDR And IVDR
With the EU’s Employment, Social Policy and Consumer Affairs Council due to discuss solutions to the MDR crisis on 9 December, the European Parliament is calling for risk-related deferrals.
CAMD Says ‘Critical Appraisal’ Needed On EU MDR Capacity Bottlenecks
Yet another EU regulatory organization has stressed the need for action to address MDR capacity problems. According to CAMD, underlying factors and causes of the crisis must be identified.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.